INS and metabolic dysfunction-associated steatotic liver disease: The pathways through which GLP‐1 RAs improve NAFLD are not completely known, but it has an indirect effect of weight loss due to the association between weight loss and increased insulin sensitivity, decreased circulating free fatty acid, and improved chronic inflammatory status.26, 27, 28